Stock Events

Stock Events

Arrowhead Pharmaceuticals (ARWR) Q4 2024 Earnings

26NovConfirmed

Q1 2024

Q2 2024

Q3 2024

Q4 2024

-1.38

-1.08

-0.77

-0.47

Details

Expected EPS

-1.120425

Actual EPS

-1.36

Surprise EPS

-0.24

Surprise Percent

+21.38%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -1.36 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.